We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Heme Oxygenase-1, Cardiac Senescence, and Myocardial Infarction: A Critical Review of the Triptych

    Purpose

    Heme oxygenase-1 (HO-1) is a crucial enzyme in heme metabolism, facilitating the breakdown of heme into biliverdin, carbon monoxide, and free...

    Inderbir Padda, Yashendra Sethi, ... Gurpreet Johal in Cardiovascular Drugs and Therapy
    Article 28 June 2024
  2. A cross-sectional study determining prevalence and factors associated with ST-segment elevation myocardial infarction and non-ST segment elevation myocardial infarction in Iran: results from fasa registry on acute myocardial infarction (FaRMI)

    Background

    Acute myocardial infarction is still a leading cause of death worldwide, accounting for roughly three million deaths yearly. This study...

    Mehdi Sharafi, Azizallah Dehghan, ... Abdulhakim Alkamel in BMC Public Health
    Article Open access 06 March 2024
  3. GLP-1 in patients with myocardial infarction complicated by cardiogenic shock—an IABP-SHOCK II-substudy

    Background

    Glucagon-like peptide-1 (GLP-1) is a gut-derived peptide secreted in response to nutritional and inflammatory stimuli. Elevated GLP-1...

    Michael Lehrke, Georg Fuernau, ... Holger Thiele in Clinical Research in Cardiology
    Article 03 January 2024
  4. Long-term outcome of patients presenting with myocardial injury or myocardial infarction

    Aims

    Patients with acute or chronic myocardial injury are frequently identified in the context of suspected myocardial infarction (MI). We aimed to...

    Paul M. Haller, Caroline Kellner, ... Johannes T. Neumann in Clinical Research in Cardiology
    Article Open access 20 November 2023
  5. Paclitaxel-induced acute myocardial infarction: a case report and literature review

    Background

    Paclitaxel is a chemotherapeutic agent commonly used for ovarian, lung, breast carcinoma, and Kaposi’s sarcoma. Its common side effects...

    Gi Eun Kim, Ayman R. Ibrahim, ... Fahmi Othman in BMC Cardiovascular Disorders
    Article Open access 19 March 2024
  6. Burden of cardiac arrhythmias in patients with acute myocardial infarction and their impact on hospitalization outcomes: insights from China acute myocardial infarction (CAMI) registry

    Background

    The coexistence of cardiac arrhythmias in patients with acute myocardial infarction (AMI) usually exhibits poor prognosis. However, there...

    Xu Xu, Zhao Wang, ... Yue** Yang in BMC Cardiovascular Disorders
    Article Open access 23 April 2024
  7. Fibrinolytic therapy use for ST-segment elevation myocardial infarction and long-term outcomes in China: 2-year results from the China Acute Myocardial Infarction Registry

    Background

    Data on fibrinolytic therapy use for ST-segment elevation myocardial infarction (STEMI) and long-term clinical outcomes in develo**...

    Chao Wu, Ling Li, ... Shubin Qiao in BMC Cardiovascular Disorders
    Article Open access 22 February 2023
  8. Long-term cardiovascular prognosis of patients with type 1 diabetes after myocardial infarction

    Background

    To explore long-term cardiovascular prognosis after myocardial infarction (MI) among patients with type 1 diabetes.

    Methods ...
    Anne M. Kerola, Anne Grete Semb, ... Ville Kytö in Cardiovascular Diabetology
    Article Open access 06 September 2022
  9. Risk of Postoperative Ischemic Stroke and Myocardial Infarction in Patients Operated for Cancer

    Background

    Risk assessment for ischemic stroke (IS) and myocardial infarction (MI) is done routinely before surgery, but the increase in risks...

    Juhana Rautiola, Johan Björklund, ... Olof Akre in Annals of Surgical Oncology
    Article Open access 13 December 2023
  10. Nicotinamide Riboside Supplementation Restores Myocardial Nicotinamide Adenine Dinucleotide Levels, Improves Survival, and Promotes Protective Environment Post Myocardial Infarction

    Aims

    Myocardial infarction (MI) is a major cause of death. Nicotinamide adenine dinucleotide (NAD + ) is a coenzyme in oxidative phosphorylation and...

    Cynthia Tannous, Rana Ghali, ... Fouad A. Zouein in Cardiovascular Drugs and Therapy
    Article 24 November 2023
  11. Favorable factors for the survival of ST-segment elevation myocardial infarction patients with medium- and high-risk thrombolysis in myocardial infarction scores

    Objective

    ST-segment myocardial infarction (STEMI) is a time-sensitive emergency. This study screened the favorable factors for the survival of STEMI...

    Zhengli Luo, Yuan Feng, ... Qiang Hu in BMC Cardiovascular Disorders
    Article Open access 13 December 2023
  12. Bone fracture is associated with incident myocardial infarction in long-term follow-up

    Background

    The association between bone fracture and cardiovascular diseases is examined in this study. While basic research has established a...

    Mei-Liang Zheng, **ang-Peng Du, ... Mei-Li Zheng in BMC Public Health
    Article Open access 23 May 2024
  13. Association between living alone and all-cause mortality of young and middle-aged patients with acute myocardial infarction: analysis of the China Acute Myocardial Infarction (CAMI) registry

    Background

    Lack of social support is a known predictor of the prognosis after acute myocardial infarction (AMI). Although as a common factor...

    Yu Jiang, **-Gang Yang, ... Yue-** Yang in BMC Public Health
    Article Open access 02 January 2024
  14. Exercise Improves Heart Function after Myocardial Infarction: The Merits of AMPK

    Background

    AMPK is considered an important protein signaling pathway that has been shown to exert prominent cardioprotective effects on the...

    **aodi Zhang, Yi Zhao, ... Dengshen Zhang in Cardiovascular Drugs and Therapy
    Article Open access 04 March 2024
  15. Atrial Fibrillation Complicating Acute Myocardial Infarction: Prevalence, Impact, and Management Considerations

    Purpose of Review

    Atrial fibrillation (AF) and myocardial infarction (MI) often coexist, and this overlap** nature leads to heightened morbidity and...

    Besher Sadat, Haider Al Taii, ... Chockalingam A. Narayanan in Current Cardiology Reports
    Article 14 March 2024
  16. A systematic review and meta-analysis of the association between sarcopenia and myocardial infarction

    Background

    Systematic review and meta-analysis of the association between sarcopenia and the development of myocardial infarction.

    Methods ...
    Feika Li, Tingting Bai, ... Jiumei Cao in BMC Geriatrics
    Article Open access 06 January 2023
  17. Myocardial infarction care in low and high socioeconomic environments: claims data analysis

    Background

    To date, claims data have not been used to study outcome differences between low and high socioeconomic status (SES) patients surviving...

    Alexander D. Hilt, Victor A. W. M. Umans, ... Saskia L. M. A. Beeres in Netherlands Heart Journal
    Article Open access 12 October 2023
  18. GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes

    Background

    Few studies explored the effect of the combination of glucose sodium-cotransporter-2 inhibitors (SGLT-2i) and glucagon-like peptide-1...

    Raffaele Marfella, Francesco Prattichizzo, ... Giuseppe Paolisso in Cardiovascular Diabetology
    Article Open access 06 January 2024
  19. Determinants of serious in-hospital complications in patients with Killip class 1/2 ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention

    Killip classification has been used to stratify the risk of patients with acute myocardial infarction (AMI). There were many reports that Killip...

    Yoichi Hori, Kenichi Sakakura, ... Hideo Fujita in Heart and Vessels
    Article 18 March 2024
  20. Effect of empagliflozin on total myocardial infarction events by type and additional coronary outcomes: insights from the randomized EMPA-REG OUTCOME trial

    Background

    The effect of empagliflozin, a sodium-glucose-co-transporter-2 inhibitor, on risk for myocardial infarction has not been fully...

    David Fitchett, Bernard Zinman, ... Søren S. Lund in Cardiovascular Diabetology
    Article Open access 11 July 2024
Did you find what you were looking for? Share feedback.